Key result
Insulin resistance in women with polycystic ovary syndrome was associated with a significantly higher atherogenic index of plasma and lower adiponectin and sVCAM-1 levels.
Why the study?
Are there differences in adipokines and soluble cell adhesion molecules between insulin resistant and non-insulin resistant women with PCOS?
Cross-Sectional (n=76)
Are there differences in adipokines and soluble cell adhesion molecules between insulin resistant and non-insulin resistant women with PCOS?
Insulin resistant women with PCOS exhibit a higher atherogenic risk profile compared to non-insulin resistant women, with differences in adiponectin and sVCAM-1 levels.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for elevated atherogenic risk in insulin-resistant PCOS; prospective studies needed before clinical adoption.
INTRODUCTION: Insulin resistance (IR) is closely associated with increased atherogenic risk. OBJECTIVE: To investigate leptin, adiponectin, soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1) levels and their relationship with each other and metabolic parameters in women with polycystic ovary syndrome (PCOS). METHODS: The study included 76 PCOS women divided into insulin resistant and non-insulin resistant. Anthropometric parameters, glucose and lipid parameters, leptin, adiponectin, sICAM-1 and sVCAM-1 were determined. Homeostasis model of IR index(HOMA-IR), atherogenic index of plasma(AIP) and leptin/adiponectin ratio were calculated. HOMA-IR > 2.5 and/or fasting plasma glucose/immunoreactive insulin ratio < 0.333 were used as markers for IR. RESULTS: Non-insulin resistant PCOS had significantly higher adiponectin and sVCAM-1 levels. AIP was significantly higher in insulin resistant PCOS. Adiponectin showed a positive correlation with sVCAM-1 and sICAM-1. CONCLUSION: Insulin resistant PCOS women were at higher atherogenic risk compared to non-insulin resistant group. sVCAM-1 data confirms the necessity of further investigations for clarifying its role in IR.
No takes yet. Share an insight, caveat, or question.
Koleva et al. (2016) conducted a cross-sectional in Polycystic ovary syndrome (PCOS) (n=76). Insulin resistance vs. Non-insulin resistance was evaluated on Leptin, adiponectin, sICAM-1, sVCAM-1 levels and metabolic parameters. Insulin resistance in women with polycystic ovary syndrome was associated with a significantly higher atherogenic index of plasma and lower adiponectin and sVCAM-1 levels.
Synapse has enriched 10 related papers. Consider them for comparative context: